Cover Image
Market Research Report
Product code 
1052533

Global Companion Diagnostic Tests Market Insights and Forecast to 2028

Published: | QYResearch | 86 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Companion Diagnostic Tests Market Insights and Forecast to 2028
Published: January 18, 2022
QYResearch
Content info: 86 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Market Analysis and Insights: Global Companion Diagnostic Tests Market

The global Companion Diagnostic Tests market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Protein Detection accounting for % of the Companion Diagnostic Tests global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical and Biotechnology Companies segment is altered to an % CAGR throughout this forecast period.

China Companion Diagnostic Tests market size is valued at US$ million in 2021, while the North America and Europe Companion Diagnostic Tests are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Companion Diagnostic Tests landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Diagnostic Tests market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Diagnostic Tests market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Diagnostic Tests market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Diagnostic Tests market.

Global Companion Diagnostic Tests Scope and Market Size

Companion Diagnostic Tests market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Protein Detection
  • DNA Detection
  • Hybridization
  • Biomarker
  • Others

Segment by Application

  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Research Institutes

By Company

  • F. Hoffman LA Roche Ltd.
  • QIAGEN, Illumina, Inc.
  • Abbott
  • Agilent Technologies, Inc.
  • Genomic Health, Inc.
  • BioMerieux SA, BioGenex
  • AGENDIA NV
  • Siemens Healthcare GmBH
  • Thermo Fisher Scientific, Inc.

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Companion Diagnostic Tests Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Protein Detection
    • 1.2.3 DNA Detection
    • 1.2.4 Hybridization
    • 1.2.5 Biomarker
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Companion Diagnostic Tests Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Pharmaceutical and Biotechnology Companies
    • 1.3.3 Medical Device Companies
    • 1.3.4 Research Institutes
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Companion Diagnostic Tests Market Perspective (2017-2028)
  • 2.2 Companion Diagnostic Tests Growth Trends by Region
    • 2.2.1 Companion Diagnostic Tests Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Companion Diagnostic Tests Historic Market Size by Region (2017-2022)
    • 2.2.3 Companion Diagnostic Tests Forecasted Market Size by Region (2023-2028)
  • 2.3 Companion Diagnostic Tests Market Dynamics
    • 2.3.1 Companion Diagnostic Tests Industry Trends
    • 2.3.2 Companion Diagnostic Tests Market Drivers
    • 2.3.3 Companion Diagnostic Tests Market Challenges
    • 2.3.4 Companion Diagnostic Tests Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Companion Diagnostic Tests Players by Revenue
    • 3.1.1 Global Top Companion Diagnostic Tests Players by Revenue (2017-2022)
    • 3.1.2 Global Companion Diagnostic Tests Revenue Market Share by Players (2017-2022)
  • 3.2 Global Companion Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Companion Diagnostic Tests Revenue
  • 3.4 Global Companion Diagnostic Tests Market Concentration Ratio
    • 3.4.1 Global Companion Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests Revenue in 2021
  • 3.5 Companion Diagnostic Tests Key Players Head office and Area Served
  • 3.6 Key Players Companion Diagnostic Tests Product Solution and Service
  • 3.7 Date of Enter into Companion Diagnostic Tests Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Tests Breakdown Data by Type

  • 4.1 Global Companion Diagnostic Tests Historic Market Size by Type (2017-2022)
  • 4.2 Global Companion Diagnostic Tests Forecasted Market Size by Type (2023-2028)

5 Companion Diagnostic Tests Breakdown Data by Application

  • 5.1 Global Companion Diagnostic Tests Historic Market Size by Application (2017-2022)
  • 5.2 Global Companion Diagnostic Tests Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Companion Diagnostic Tests Market Size (2017-2028)
  • 6.2 North America Companion Diagnostic Tests Market Size by Type
    • 6.2.1 North America Companion Diagnostic Tests Market Size by Type (2017-2022)
    • 6.2.2 North America Companion Diagnostic Tests Market Size by Type (2023-2028)
    • 6.2.3 North America Companion Diagnostic Tests Market Share by Type (2017-2028)
  • 6.3 North America Companion Diagnostic Tests Market Size by Application
    • 6.3.1 North America Companion Diagnostic Tests Market Size by Application (2017-2022)
    • 6.3.2 North America Companion Diagnostic Tests Market Size by Application (2023-2028)
    • 6.3.3 North America Companion Diagnostic Tests Market Share by Application (2017-2028)
  • 6.4 North America Companion Diagnostic Tests Market Size by Country
    • 6.4.1 North America Companion Diagnostic Tests Market Size by Country (2017-2022)
    • 6.4.2 North America Companion Diagnostic Tests Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Companion Diagnostic Tests Market Size (2017-2028)
  • 7.2 Europe Companion Diagnostic Tests Market Size by Type
    • 7.2.1 Europe Companion Diagnostic Tests Market Size by Type (2017-2022)
    • 7.2.2 Europe Companion Diagnostic Tests Market Size by Type (2023-2028)
    • 7.2.3 Europe Companion Diagnostic Tests Market Share by Type (2017-2028)
  • 7.3 Europe Companion Diagnostic Tests Market Size by Application
    • 7.3.1 Europe Companion Diagnostic Tests Market Size by Application (2017-2022)
    • 7.3.2 Europe Companion Diagnostic Tests Market Size by Application (2023-2028)
    • 7.3.3 Europe Companion Diagnostic Tests Market Share by Application (2017-2028)
  • 7.4 Europe Companion Diagnostic Tests Market Size by Country
    • 7.4.1 Europe Companion Diagnostic Tests Market Size by Country (2017-2022)
    • 7.4.2 Europe Companion Diagnostic Tests Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Companion Diagnostic Tests Market Size (2017-2028)
  • 8.2 Asia-Pacific Companion Diagnostic Tests Market Size by Type
    • 8.2.1 Asia-Pacific Companion Diagnostic Tests Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Companion Diagnostic Tests Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Companion Diagnostic Tests Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Companion Diagnostic Tests Market Size by Application
    • 8.3.1 Asia-Pacific Companion Diagnostic Tests Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Companion Diagnostic Tests Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Companion Diagnostic Tests Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Companion Diagnostic Tests Market Size by Region
    • 8.4.1 Asia-Pacific Companion Diagnostic Tests Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Companion Diagnostic Tests Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Companion Diagnostic Tests Market Size (2017-2028)
  • 9.2 Latin America Companion Diagnostic Tests Market Size by Type
    • 9.2.1 Latin America Companion Diagnostic Tests Market Size by Type (2017-2022)
    • 9.2.2 Latin America Companion Diagnostic Tests Market Size by Type (2023-2028)
    • 9.2.3 Latin America Companion Diagnostic Tests Market Share by Type (2017-2028)
  • 9.3 Latin America Companion Diagnostic Tests Market Size by Application
    • 9.3.1 Latin America Companion Diagnostic Tests Market Size by Application (2017-2022)
    • 9.3.2 Latin America Companion Diagnostic Tests Market Size by Application (2023-2028)
    • 9.3.3 Latin America Companion Diagnostic Tests Market Share by Application (2017-2028)
  • 9.4 Latin America Companion Diagnostic Tests Market Size by Country
    • 9.4.1 Latin America Companion Diagnostic Tests Market Size by Country (2017-2022)
    • 9.4.2 Latin America Companion Diagnostic Tests Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Companion Diagnostic Tests Market Size (2017-2028)
  • 10.2 Middle East & Africa Companion Diagnostic Tests Market Size by Type
    • 10.2.1 Middle East & Africa Companion Diagnostic Tests Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Companion Diagnostic Tests Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Companion Diagnostic Tests Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Companion Diagnostic Tests Market Size by Application
    • 10.3.1 Middle East & Africa Companion Diagnostic Tests Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Companion Diagnostic Tests Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Companion Diagnostic Tests Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Companion Diagnostic Tests Market Size by Country
    • 10.4.1 Middle East & Africa Companion Diagnostic Tests Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Companion Diagnostic Tests Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 F. Hoffman LA Roche Ltd.
    • 11.1.1 F. Hoffman LA Roche Ltd. Company Details
    • 11.1.2 F. Hoffman LA Roche Ltd. Business Overview
    • 11.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Introduction
    • 11.1.4 F. Hoffman LA Roche Ltd. Revenue in Companion Diagnostic Tests Business (2017-2022)
    • 11.1.5 F. Hoffman LA Roche Ltd. Recent Developments
  • 11.2 QIAGEN, Illumina, Inc.
    • 11.2.1 QIAGEN, Illumina, Inc. Company Details
    • 11.2.2 QIAGEN, Illumina, Inc. Business Overview
    • 11.2.3 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Introduction
    • 11.2.4 QIAGEN, Illumina, Inc. Revenue in Companion Diagnostic Tests Business (2017-2022)
    • 11.2.5 QIAGEN, Illumina, Inc. Recent Developments
  • 11.3 Abbott
    • 11.3.1 Abbott Company Details
    • 11.3.2 Abbott Business Overview
    • 11.3.3 Abbott Companion Diagnostic Tests Introduction
    • 11.3.4 Abbott Revenue in Companion Diagnostic Tests Business (2017-2022)
    • 11.3.5 Abbott Recent Developments
  • 11.4 Agilent Technologies, Inc.
    • 11.4.1 Agilent Technologies, Inc. Company Details
    • 11.4.2 Agilent Technologies, Inc. Business Overview
    • 11.4.3 Agilent Technologies, Inc. Companion Diagnostic Tests Introduction
    • 11.4.4 Agilent Technologies, Inc. Revenue in Companion Diagnostic Tests Business (2017-2022)
    • 11.4.5 Agilent Technologies, Inc. Recent Developments
  • 11.5 Genomic Health, Inc.
    • 11.5.1 Genomic Health, Inc. Company Details
    • 11.5.2 Genomic Health, Inc. Business Overview
    • 11.5.3 Genomic Health, Inc. Companion Diagnostic Tests Introduction
    • 11.5.4 Genomic Health, Inc. Revenue in Companion Diagnostic Tests Business (2017-2022)
    • 11.5.5 Genomic Health, Inc. Recent Developments
  • 11.6 BioMerieux SA, BioGenex
    • 11.6.1 BioMerieux SA, BioGenex Company Details
    • 11.6.2 BioMerieux SA, BioGenex Business Overview
    • 11.6.3 BioMerieux SA, BioGenex Companion Diagnostic Tests Introduction
    • 11.6.4 BioMerieux SA, BioGenex Revenue in Companion Diagnostic Tests Business (2017-2022)
    • 11.6.5 BioMerieux SA, BioGenex Recent Developments
  • 11.7 AGENDIA NV
    • 11.7.1 AGENDIA NV Company Details
    • 11.7.2 AGENDIA NV Business Overview
    • 11.7.3 AGENDIA NV Companion Diagnostic Tests Introduction
    • 11.7.4 AGENDIA NV Revenue in Companion Diagnostic Tests Business (2017-2022)
    • 11.7.5 AGENDIA NV Recent Developments
  • 11.8 Siemens Healthcare GmBH
    • 11.8.1 Siemens Healthcare GmBH Company Details
    • 11.8.2 Siemens Healthcare GmBH Business Overview
    • 11.8.3 Siemens Healthcare GmBH Companion Diagnostic Tests Introduction
    • 11.8.4 Siemens Healthcare GmBH Revenue in Companion Diagnostic Tests Business (2017-2022)
    • 11.8.5 Siemens Healthcare GmBH Recent Developments
  • 11.9 Thermo Fisher Scientific, Inc.
    • 11.9.1 Thermo Fisher Scientific, Inc. Company Details
    • 11.9.2 Thermo Fisher Scientific, Inc. Business Overview
    • 11.9.3 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Introduction
    • 11.9.4 Thermo Fisher Scientific, Inc. Revenue in Companion Diagnostic Tests Business (2017-2022)
    • 11.9.5 Thermo Fisher Scientific, Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Companion Diagnostic Tests Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Protein Detection
  • Table 3. Key Players of DNA Detection
  • Table 4. Key Players of Hybridization
  • Table 5. Key Players of Biomarker
  • Table 6. Key Players of Others
  • Table 7. Global Companion Diagnostic Tests Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 8. Global Companion Diagnostic Tests Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 9. Global Companion Diagnostic Tests Market Size by Region (2017-2022) & (US$ Million)
  • Table 10. Global Companion Diagnostic Tests Market Share by Region (2017-2022)
  • Table 11. Global Companion Diagnostic Tests Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 12. Global Companion Diagnostic Tests Market Share by Region (2023-2028)
  • Table 13. Companion Diagnostic Tests Market Trends
  • Table 14. Companion Diagnostic Tests Market Drivers
  • Table 15. Companion Diagnostic Tests Market Challenges
  • Table 16. Companion Diagnostic Tests Market Restraints
  • Table 17. Global Companion Diagnostic Tests Revenue by Players (2017-2022) & (US$ Million)
  • Table 18. Global Companion Diagnostic Tests Revenue Share by Players (2017-2022)
  • Table 19. Global Top Companion Diagnostic Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Tests as of 2021)
  • Table 20. Ranking of Global Top Companion Diagnostic Tests Companies by Revenue (US$ Million) in 2021
  • Table 21. Global 5 Largest Players Market Share by Companion Diagnostic Tests Revenue (CR5 and HHI) & (2017-2022)
  • Table 22. Key Players Headquarters and Area Served
  • Table 23. Key Players Companion Diagnostic Tests Product Solution and Service
  • Table 24. Date of Enter into Companion Diagnostic Tests Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Companion Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
  • Table 27. Global Companion Diagnostic Tests Revenue Market Share by Type (2017-2022)
  • Table 28. Global Companion Diagnostic Tests Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 29. Global Companion Diagnostic Tests Revenue Market Share by Type (2023-2028)
  • Table 30. Global Companion Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
  • Table 31. Global Companion Diagnostic Tests Revenue Share by Application (2017-2022)
  • Table 32. Global Companion Diagnostic Tests Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 33. Global Companion Diagnostic Tests Revenue Share by Application (2023-2028)
  • Table 34. North America Companion Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
  • Table 35. North America Companion Diagnostic Tests Market Size by Type (2023-2028) & (US$ Million)
  • Table 36. North America Companion Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
  • Table 37. North America Companion Diagnostic Tests Market Size by Application (2023-2028) & (US$ Million)
  • Table 38. North America Companion Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
  • Table 39. North America Companion Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
  • Table 40. Europe Companion Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
  • Table 41. Europe Companion Diagnostic Tests Market Size by Type (2023-2028) & (US$ Million)
  • Table 42. Europe Companion Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
  • Table 43. Europe Companion Diagnostic Tests Market Size by Application (2023-2028) & (US$ Million)
  • Table 44. Europe Companion Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
  • Table 45. Europe Companion Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
  • Table 46. Asia Pacific Companion Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
  • Table 47. Asia Pacific Companion Diagnostic Tests Market Size by Type (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Companion Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Companion Diagnostic Tests Market Size by Application (2023-2028) & (US$ Million)
  • Table 50. Asia Pacific Companion Diagnostic Tests Market Size by Region (2017-2022) & (US$ Million)
  • Table 51. Asia Pacific Companion Diagnostic Tests Market Size by Region (2023-2028) & (US$ Million)
  • Table 52. Latin America Companion Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
  • Table 53. Latin America Companion Diagnostic Tests Market Size by Type (2023-2028) & (US$ Million)
  • Table 54. Latin America Companion Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
  • Table 55. Latin America Companion Diagnostic Tests Market Size by Application (2023-2028) & (US$ Million)
  • Table 56. Latin America Companion Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
  • Table 57. Latin America Companion Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
  • Table 58. Middle East and Africa Companion Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
  • Table 59. Middle East and Africa Companion Diagnostic Tests Market Size by Type (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Companion Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Companion Diagnostic Tests Market Size by Application (2023-2028) & (US$ Million)
  • Table 62. Middle East and Africa Companion Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
  • Table 63. Middle East and Africa Companion Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
  • Table 64. F. Hoffman LA Roche Ltd. Company Details
  • Table 65. F. Hoffman LA Roche Ltd. Business Overview
  • Table 66. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product
  • Table 67. F. Hoffman LA Roche Ltd. Revenue in Companion Diagnostic Tests Business (2017-2022) & (US$ Million)
  • Table 68. F. Hoffman LA Roche Ltd. Recent Developments
  • Table 69. QIAGEN, Illumina, Inc. Company Details
  • Table 70. QIAGEN, Illumina, Inc. Business Overview
  • Table 71. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Product
  • Table 72. QIAGEN, Illumina, Inc. Revenue in Companion Diagnostic Tests Business (2017-2022) & (US$ Million)
  • Table 73. QIAGEN, Illumina, Inc. Recent Developments
  • Table 74. Abbott Company Details
  • Table 75. Abbott Business Overview
  • Table 76. Abbott Companion Diagnostic Tests Product
  • Table 77. Abbott Revenue in Companion Diagnostic Tests Business (2017-2022) & (US$ Million)
  • Table 78. Abbott Recent Developments
  • Table 79. Agilent Technologies, Inc. Company Details
  • Table 80. Agilent Technologies, Inc. Business Overview
  • Table 81. Agilent Technologies, Inc. Companion Diagnostic Tests Product
  • Table 82. Agilent Technologies, Inc. Revenue in Companion Diagnostic Tests Business (2017-2022) & (US$ Million)
  • Table 83. Agilent Technologies, Inc. Recent Developments
  • Table 84. Genomic Health, Inc. Company Details
  • Table 85. Genomic Health, Inc. Business Overview
  • Table 86. Genomic Health, Inc. Companion Diagnostic Tests Product
  • Table 87. Genomic Health, Inc. Revenue in Companion Diagnostic Tests Business (2017-2022) & (US$ Million)
  • Table 88. Genomic Health, Inc. Recent Developments
  • Table 89. BioMerieux SA, BioGenex Company Details
  • Table 90. BioMerieux SA, BioGenex Business Overview
  • Table 91. BioMerieux SA, BioGenex Companion Diagnostic Tests Product
  • Table 92. BioMerieux SA, BioGenex Revenue in Companion Diagnostic Tests Business (2017-2022) & (US$ Million)
  • Table 93. BioMerieux SA, BioGenex Recent Developments
  • Table 94. AGENDIA NV Company Details
  • Table 95. AGENDIA NV Business Overview
  • Table 96. AGENDIA NV Companion Diagnostic Tests Product
  • Table 97. AGENDIA NV Revenue in Companion Diagnostic Tests Business (2017-2022) & (US$ Million)
  • Table 98. AGENDIA NV Recent Developments
  • Table 99. Siemens Healthcare GmBH Company Details
  • Table 100. Siemens Healthcare GmBH Business Overview
  • Table 101. Siemens Healthcare GmBH Companion Diagnostic Tests Product
  • Table 102. Siemens Healthcare GmBH Revenue in Companion Diagnostic Tests Business (2017-2022) & (US$ Million)
  • Table 103. Siemens Healthcare GmBH Recent Developments
  • Table 104. Thermo Fisher Scientific, Inc. Company Details
  • Table 105. Thermo Fisher Scientific, Inc. Business Overview
  • Table 106. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Product
  • Table 107. Thermo Fisher Scientific, Inc. Revenue in Companion Diagnostic Tests Business (2017-2022) & (US$ Million)
  • Table 108. Thermo Fisher Scientific, Inc. Recent Developments
  • Table 109. Research Programs/Design for This Report
  • Table 110. Key Data Information from Secondary Sources
  • Table 111. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Companion Diagnostic Tests Market Share by Type: 2021 VS 2028
  • Figure 2. Protein Detection Features
  • Figure 3. DNA Detection Features
  • Figure 4. Hybridization Features
  • Figure 5. Biomarker Features
  • Figure 6. Others Features
  • Figure 7. Global Companion Diagnostic Tests Market Share by Application: 2021 VS 2028
  • Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
  • Figure 9. Medical Device Companies Case Studies
  • Figure 10. Research Institutes Case Studies
  • Figure 11. Companion Diagnostic Tests Report Years Considered
  • Figure 12. Global Companion Diagnostic Tests Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 13. Global Companion Diagnostic Tests Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 14. Global Companion Diagnostic Tests Market Share by Region: 2021 VS 2028
  • Figure 15. Global Companion Diagnostic Tests Market Share by Players in 2021
  • Figure 16. Global Top Companion Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Tests as of 2021)
  • Figure 17. The Top 10 and 5 Players Market Share by Companion Diagnostic Tests Revenue in 2021
  • Figure 18. North America Companion Diagnostic Tests Market Size YoY (2017-2028) & (US$ Million)
  • Figure 19. North America Companion Diagnostic Tests Market Size Market Share by Type (2017-2028)
  • Figure 20. North America Companion Diagnostic Tests Market Size Market Share by Application (2017-2028)
  • Figure 21. North America Companion Diagnostic Tests Market Size Share by Country (2017-2028)
  • Figure 22. United States Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Canada Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Europe Companion Diagnostic Tests Market Size YoY (2017-2028) & (US$ Million)
  • Figure 25. Europe Companion Diagnostic Tests Market Size Market Share by Type (2017-2028)
  • Figure 26. Europe Companion Diagnostic Tests Market Size Market Share by Application (2017-2028)
  • Figure 27. Europe Companion Diagnostic Tests Market Size Share by Country (2017-2028)
  • Figure 28. Germany Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. France Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. U.K. Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Italy Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Russia Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Nordic Countries Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Asia-Pacific Companion Diagnostic Tests Market Size YoY (2017-2028) & (US$ Million)
  • Figure 35. Asia Pacific Companion Diagnostic Tests Market Size Market Share by Type (2017-2028)
  • Figure 36. Asia Pacific Companion Diagnostic Tests Market Size Market Share by Application (2017-2028)
  • Figure 37. Asia Pacific Companion Diagnostic Tests Market Size Share by Region (2017-2028)
  • Figure 38. China Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Japan Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. South Korea Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Southeast Asia Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. India Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Australia Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. Latin America Companion Diagnostic Tests Market Size YoY (2017-2028) & (US$ Million)
  • Figure 45. Latin America Companion Diagnostic Tests Market Size Market Share by Type (2017-2028)
  • Figure 46. Latin America Companion Diagnostic Tests Market Size Market Share by Application (2017-2028)
  • Figure 47. Latin America Companion Diagnostic Tests Market Size Share by Country (2017-2028)
  • Figure 48. Mexico Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Brazil Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Middle East & Africa Companion Diagnostic Tests Market Size YoY (2017-2028) & (US$ Million)
  • Figure 51. Middle East and Africa Companion Diagnostic Tests Market Size Market Share by Type (2017-2028)
  • Figure 52. Middle East and Africa Companion Diagnostic Tests Market Size Market Share by Application (2017-2028)
  • Figure 53. Middle East and Africa Companion Diagnostic Tests Market Size Share by Country (2017-2028)
  • Figure 54. Turkey Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Saudi Arabia Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. UAE Companion Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 57. F. Hoffman LA Roche Ltd. Revenue Growth Rate in Companion Diagnostic Tests Business (2017-2022)
  • Figure 58. QIAGEN, Illumina, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2017-2022)
  • Figure 59. Abbott Revenue Growth Rate in Companion Diagnostic Tests Business (2017-2022)
  • Figure 60. Agilent Technologies, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2017-2022)
  • Figure 61. Genomic Health, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2017-2022)
  • Figure 62. BioMerieux SA, BioGenex Revenue Growth Rate in Companion Diagnostic Tests Business (2017-2022)
  • Figure 63. AGENDIA NV Revenue Growth Rate in Companion Diagnostic Tests Business (2017-2022)
  • Figure 64. Siemens Healthcare GmBH Revenue Growth Rate in Companion Diagnostic Tests Business (2017-2022)
  • Figure 65. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Companion Diagnostic Tests Business (2017-2022)
  • Figure 66. Bottom-up and Top-down Approaches for This Report
  • Figure 67. Data Triangulation
  • Figure 68. Key Executives Interviewed